|
|
Sara K. Hansen, Marcelina Párrizas, Maria L. Jensen, Stepanka Pruhova, Jakob Ek, Sylvia F. Boj, Anders Johansen, Miguel A. Maestro, Francisca Rivera, Hans Eiberg, Michal Andel, Jan Lebl, Oluf Pedersen, Jorge Ferrer, Torben Hansen
J Clin Invest. 2002;
110(6):827
doi:10.1172/JCI15085
Abstract |
Full text
| PDF

M
utations in the genes encoding hepatocyte nuclear factor 4α (HNF-4α) and HNF-1α impair insulin secretion and cause maturity onset diabetes of the young (MODY). HNF-4α is known to be an essential positive regulator of HNF-1α. More recent data demonstrates that HNF-4α expression is dependent on HNF-1α in mouse pancreatic islets and exocrine cells. This effect is mediated by binding of HNF-1α to a tissue-specific promoter (P2) located 45.6 kb upstream from the previously characterized Hnf4α promoter (P1). Here we report that the expression of HNF-4α in human islets and exocrine cells is primarily mediated by the P2 promoter. Furthermore, we describe a G → A mutation in a conserved nucleotide position of the HNF-1α binding site of the P2 promoter, which cosegregates with MODY. The mutation results in decreased affinity for HNF-1α, and consequently in reduced HNF-1α–dependent activation. These findings provide genetic evidence that HNF-1α serves as an upstream regulator of HNF-4α and interacts directly with the P2 promoter in human pancreatic cells. Furthermore, they indicate that this regulation is essential to maintain normal pancreatic function.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(12)
| Title and authors |
Publication |
Year |
Role of HNF-1α and HNF-1β on insulin, IGF-1 and other potential target genes
Sachiko Kitanaka
|
Expert Rev Endocrinol Metab
|
2008 |
Insights on pathogenesis of type 2 diabetes from MODY genetics
Michael N. Weedon, Timothy M. Frayling
|
Curr Diab Rep
|
2007 |
HNF4A genetic variants: role in diabetes
Latisha Love-Gregory, M Alan Permutt
|
Current Opinion in Clinical Nutrition and Metabolic Care
|
2007 |
Alternate mRNA processing of the hepatocyte nuclear factor genes and its role in monogenic diabetes
Lorna W Harries
|
Expert Rev Endocrinol Metab
|
2006 |
Dysregulated expression of P1 and P2 promoter-driven hepatocyte nuclear factor-4α in the pathogenesis of human cancer
T Tanaka, S Jiang, H Hotta, K Takano, H Iwanari, K Sumi, K Daigo, R Ohashi, M Sugai, C Ikegame, H Umezu, Y Hirayama, Y Midorikawa, Y Hippo, A Watanabe, Y Uchiyama, G Hasegawa, PC Reid, H Aburatani, T Hamakubo, J Sakai, M Naito, T Kodama
|
J. Pathol.
|
2006 |
Novel Genetic Variations and Haplotypes of Hepatocyte Nuclear Factor 4α (HNF4A) Found in Japanese Type II Diabetic Patients
Hiromi FUKUSHIMA-UESAKA, Yoshiro SAITO, Keiko MAEKAWA, Mayumi SAEKI, Naoyuki KAMATANI, Hiroshi KAJIO, Nobuaki KUZUYA, Kazuki YASUDA, Jun-ichi SAWADA
|
DMPK
|
2006 |
The MODY1 gene HNF-4α regulates selected genes involved in insulin secretion
Rana K. Gupta, Marko Z. Vatamaniuk, Catherine S. Lee, Reed C. Flaschen, James T. Fulmer, Franz M. Matschinsky, Stephen A. Duncan, Klaus H. Kaestner
|
J. Clin. Invest.
|
2005 |
Variation near the hepatocyte nuclear factor (HNF)-4? gene associates with type 2 diabetes in the Danish population
S. K. Hansen, C. S. Rose, C. Gl�mer, T. Drivsholm, K. Borch-Johnsen, T. J�rgensen, O. Pedersen, T. Hansen
|
Diabetologia
|
2005 |
Dissociation of the Hepatic Phenotype from HNF4 and HNF1α Expression
Gary A. Bulla, David M. Kraus
|
Biosci Rep
|
2005 |
The role of HNF4A variants in the risk of type 2 diabetes
Karen L. Mohlke, Michael Boehnke
|
Curr Diab Rep
|
2005 |
|